Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance

Details for Australian Patent Application No. 2007272619 (hide)

International Classifications

Event Publications

12 February 2009 PCT application entered the National Phase

PCT publication WO2008/008720 Priority application(s): WO2008/008720

19 February 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 19 Jan 2009

12 March 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Synapsin Pharmaceuticals, Inc., Application No. 2007272619, under INID(54), correct the title to read Compositions and methods relating to Solenopsins and their uses in treating neurological disorders and enhancing physical performance

27 January 2011 Amendment Made

The nature of the amendment is: Amend the invention title to read Compositions and methods relating to Solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.